Spolarics Z, Navarro L
Department of Anatomy, Cell Biology and Injury Sciences, New Jersey Medical School, Newark.
J Leukoc Biol. 1994 Oct;56(4):453-7. doi: 10.1002/jlb.56.4.453.
The aim of the study was to elucidate the effect of lipopolysaccharide (LPS) administration in vivo (Escherichia coli endotoxin, 1 mg/kg body weight) on the expression and cellular activity of glucose-6-phosphate dehydrogenase (G6PDH, EC 1.1.1.49), the rate-limiting enzyme of the hexose monophosphate shunt in hepatic cells. Under basal conditions, Kupffer cells displayed higher activity of G6PDH than endothelial or parenchymal cells. In vivo LPS treatments for 7 and 22 h resulted in 40 and 60% increases, respectively, in the cellular activity of G6PDH in Kupffer cells. G6PDH activity was increased by 140 and 90% after 7- and 22-h LPS treatments in endothelial cells. G6PDH activity in parenchymal cells prepared from animals after 22 h of LPS treatment was decreased by approximately 60% compared with that in cells from saline-injected animals. Total cellular RNA or protein extracts from these cells were analyzed by Northern or Western blots. Under basal conditions, G6PDH mRNA levels relative to total cellular RNA were higher in Kupffer than in endothelial cells and were not detectable in parenchyma cells. LPS injection caused a time-dependent increase in G6PDH mRNA expression in Kupffer and endothelial cells. Western blot analysis of Kupffer cell extracts also showed that LPS treatments caused markedly elevated expression of protein in these cells. These results show that endotoxemia results in marked induction of G6PDH in Kupffer and hepatic endothelial cells but has no such effect in the parenchymal cells. These findings also suggest that the elevated cellular expression of G6PDH is an important regulatory event in the adaptive responses of hepatic nonparenchymal cells to infections. The elevated expression of G6PDH may be important for support of the upregulated NADPH-dependent pathways, such as superoxide anion and nitric oxide production, macromolecular synthesis, or the maintenance of cellular glutathione status.
本研究的目的是阐明体内给予脂多糖(LPS,大肠杆菌内毒素,1 mg/kg体重)对肝细胞中磷酸己糖支路的限速酶葡萄糖-6-磷酸脱氢酶(G6PDH,EC 1.1.1.49)的表达及细胞活性的影响。在基础条件下,库普弗细胞的G6PDH活性高于内皮细胞或实质细胞。体内给予LPS 7小时和22小时后,库普弗细胞中G6PDH的细胞活性分别增加了40%和60%。LPS处理7小时和22小时后,内皮细胞中G6PDH活性分别增加了140%和90%。与注射生理盐水动物的细胞相比,LPS处理22小时后动物制备的实质细胞中G6PDH活性降低了约60%。通过Northern印迹或Western印迹分析这些细胞的总细胞RNA或蛋白质提取物。在基础条件下,相对于总细胞RNA的G6PDH mRNA水平在库普弗细胞中高于内皮细胞,在实质细胞中未检测到。注射LPS导致库普弗细胞和内皮细胞中G6PDH mRNA表达呈时间依赖性增加。对库普弗细胞提取物的Western印迹分析还表明,LPS处理导致这些细胞中蛋白质表达明显升高。这些结果表明,内毒素血症导致库普弗细胞和肝内皮细胞中G6PDH的显著诱导,但对实质细胞无此作用。这些发现还表明,G6PDH细胞表达的升高是肝非实质细胞对感染适应性反应中的一个重要调节事件。G6PDH表达的升高对于支持上调的NADPH依赖性途径可能很重要,如超氧阴离子和一氧化氮的产生、大分子合成或细胞内谷胱甘肽状态的维持。